Pages that link to "Q47953895"
Jump to navigation
Jump to search
The following pages link to Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression (Q47953895):
Displaying 50 items.
- Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries (Q28534753) (← links)
- Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia (Q28552868) (← links)
- Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms (Q30489045) (← links)
- High-throughput analysis of antimalarial susceptibility data by the worldwide antimalarial resistance network (WWARN) In Vitro analysis and reporting tool (Q30619647) (← links)
- Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia (Q34298916) (← links)
- Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin (Q34597550) (← links)
- Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance (Q34710568) (← links)
- Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season (Q35101288) (← links)
- Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans (Q35105899) (← links)
- Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites (Q35139505) (← links)
- Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs (Q35533577) (← links)
- Monitoring PfMDR1 transport in Plasmodium falciparum (Q35848309) (← links)
- Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance (Q35859975) (← links)
- Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana (Q35920087) (← links)
- Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions (Q36066881) (← links)
- Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates (Q36372815) (← links)
- Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011 (Q36643101) (← links)
- Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study (Q36711959) (← links)
- Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014. (Q36884930) (← links)
- In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal (Q36921820) (← links)
- In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites (Q37023312) (← links)
- Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Camb (Q37028482) (← links)
- Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study (Q37205700) (← links)
- Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies (Q37240876) (← links)
- Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers (Q37263344) (← links)
- Field-based flow cytometry for ex vivo characterization of Plasmodium vivax and P. falciparum antimalarial sensitivity (Q37263905) (← links)
- PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria (Q37316906) (← links)
- A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs (Q37426615) (← links)
- Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin (Q37544298) (← links)
- Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors (Q38655003) (← links)
- A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity (Q38739986) (← links)
- An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs (Q38970753) (← links)
- Antimalarial Drug Resistance: A Threat to Malaria Elimination (Q39176615) (← links)
- Antiplasmodial activity of targeted zinc(II)-dipicolylamine complexes (Q39396680) (← links)
- Antiplasmodial activities of dyes against Plasmodium falciparum asexual and sexual stages: Contrasted uptakes of triarylmethanes Brilliant green, Green S (E142), and Patent Blue V (E131) by erythrocytes (Q40050625) (← links)
- Antiplasmodial activity of selected medicinal plants used to treat malaria in Ghana (Q41915110) (← links)
- Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments (Q42013526) (← links)
- Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum. (Q48022305) (← links)
- Antiplasmodial activity of two medicinal plants against clinical isolates of Plasmodium falciparum and Plasmodium berghei infected mice. (Q52680643) (← links)
- Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium. (Q53696257) (← links)
- Artemisinin-Resistant Plasmodium falciparum with High Survival Rates, Uganda, 2014-2016. (Q53701065) (← links)
- Status of imported malaria on Réunion Island in 2016. (Q55327725) (← links)
- Repurposing drugs to target the malaria parasite unfolding protein response. (Q55560161) (← links)
- Chloroquine exposure triggers distinct cellular responses in sensitive versus resistant Plasmodium falciparum parasites (Q56358062) (← links)
- Synthesis and antimicrobial/antimalarial activities of novel naphthalimido trans-β-lactam derivatives (Q56793233) (← links)
- Lack of significant recovery of chloroquine sensitivity in Plasmodium falciparum parasites following discontinuance of chloroquine use in Papua New Guinea (Q59809015) (← links)
- Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda (Q89763578) (← links)
- Uptake of a fluorescently tagged chloroquine analogue is reduced in CQ-resistant compared to CQ-sensitive Plasmodium falciparum parasites (Q90569859) (← links)
- Design and synthesis of simplified speciophylline analogues and β-carbolines as active molecules against Plasmodium falciparum (Q93381873) (← links)
- Evaluation of antiplasmodial activity of extracts from endemic medicinal plants used to treat malaria in Côte d'Ivoire (Q98465983) (← links)